国产HPV疫苗获批上市，定价329元/支（双语）

　　近日，国家药监局批准首个国产双价人乳头瘤病毒疫苗(大肠杆菌)(商品名：馨可宁，Cecolin)的上市注册申请。

　　China has approved its first domestically made vaccine against the cancer-causing human papillomavirus for use by females aged 9 to 45, providing an alternative to foreign drugmakers' products, according to the National Medical Products Administration.

　　此次获批的双价人乳头瘤病毒疫苗(大肠杆菌)系国内首家申报生产的HPV疫苗，针对HPV16、18型，被纳入国家重大新药创制专项支持。

　　The newly approved vaccine is designed to protect against Type 16 and Type 18 HPV, the two most common virus strains that lead to cervical cancer, the administration said in a notice released on Tuesday.

　　▌定价为329元/支，适用于9-45岁女性

　　该产品由厦门大学夏宁邵团队和厦门万泰共同研发，是首个获批的国产人乳头瘤病毒疫苗，适用于9-45岁女性。

　　The new vaccine, known as Cecolin, was jointly developed by INNOVAX, a biotechnology company based in Xiamen, Fujian province, in cooperation with Xiamen University.

　　据厦门万泰消息，馨可宁的定价为329元/支，9-14岁女性只需要接种2针，15-45岁女性接种3针，该产品目前正准备投产。